Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,808 | -7,523 | -23,230 | -12,795 | -7,763 |
| Depreciation Amortization | 362 | 167 | 410 | 293 | 169 |
| Other Working Capital | -4,241 | -3,534 | 2,900 | 287 | -221 |
| Other Operating Activity | 2,472 | 1,131 | 7,730 | 1,919 | 1,195 |
| Operating Cash Flow | $-16,215 | $-9,759 | $-12,190 | $-10,296 | $-6,620 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,433 | -673 | -1,020 | -1,011 | -803 |
| Purchase Sale Intangibles | N/A | N/A | -175 | -175 | -175 |
| Other Investing Activity | 0 | 0 | -180 | -175 | -175 |
| Investing Cash Flow | $-1,433 | $-673 | $-1,200 | $-1,186 | $-978 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 66,163 | 0 | N/A |
| Other Financing Activity | 0 | 0 | -4,163 | -44 | -22 |
| Financing Cash Flow | $N/A | $N/A | $62,000 | $-44 | $-22 |
| Beginning Cash Position | 63,584 | 63,534 | 14,920 | 14,976 | 14,976 |
| End Cash Position | 45,936 | 53,102 | 63,530 | 3,450 | 7,356 |
| Net Cash Flow | $-17,648 | $-10,432 | $48,600 | $-11,526 | $-7,620 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,215 | -9,759 | -12,190 | -10,296 | -6,620 |
| Capital Expenditure | -1,433 | -673 | -1,030 | -1,011 | -803 |
| Free Cash Flow | -17,648 | -10,432 | -13,220 | -11,307 | -7,423 |